迈得医疗跌2.05%，成交额464.56万元，主力资金净流入35.34万元

Core Viewpoint - Midea Medical's stock has experienced fluctuations, with a year-to-date increase of 41.57% but a recent decline in the last 5, 20, and 60 trading days [1] Financial Performance - For the period from January to September 2025, Midea Medical achieved a revenue of 225 million yuan, representing a year-on-year growth of 2.31% [2] - The net profit attributable to the parent company was 8.84 million yuan, showing a year-on-year increase of 15.82% [2] Stock Market Activity - As of December 2, Midea Medical's stock price was 15.29 yuan per share, with a market capitalization of 2.54 billion yuan [1] - The stock has seen a net inflow of 353,400 yuan from main funds, with a significant portion of buying activity [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the last occurrence on August 26, where it recorded a net buy of -57.70 million yuan [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 4,528, while the average circulating shares per person decreased by 15.97% to 36,709 shares [2] - The top ten circulating shareholders include notable funds, with some new entrants and exits among them [3] Dividend Distribution - Midea Medical has distributed a total of 202 million yuan in dividends since its A-share listing, with 99.30 million yuan distributed over the past three years [3] Business Overview - Midea Medical, established in March 2003 and listed in December 2019, specializes in the research, production, sales, and service of medical consumables and intelligent equipment [1] - The main revenue sources are safety infusion products (48.75%), blood purification products (26.27%), and other products (24.98%) [1]